TCTAP A-004 Early Clinical Outcomes Following “Off-” Versus “On-label” Indications of Bioresorbable Vascular Scaffolds for the Treatment of 1505 Patients with Coronary Artery Disease: Results from the Prospective “Registro Absorb Italiano” (RAI Registry)
2017
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI